BiOptic has more than 40 distributors around the world, and they are our most important partners. It is important for us to provide face-to-face training courses for them.
Zhejiang BiOptic has received Class I medical device certification
2023-04-27
BiOptic registered its’ second-tier subsidiary Zhejiang BiOptic on NOV 23rd, 2021, and has received Class I medical device certification. In the future, for the overall production and manufacturing capacity of BiOptic Group, it will be possible to have more diverse plans and increase productivity to effectively match the needs of the global market.
Qsep Ultra will make its first debut in Pittcon 2023
2023-03-13
BiOptic Inc. will attend Pittcon 2023 in Pennsylvania Convention Center from March 20th to 22nd, presenting the unique Qsep Series products with the “Open Platform” concept, which is the best solution for overall genetic analysis.
Analytica Vietnam is Vietnam's largest trade fair for the analysis, laboratory-technology and biotechnology sectors. This international business platform is designed to take exhibitors to new-developing marketplaces of significant interest.
BiOptic has received ISO13485 certification from TÜV Rheinland - BiOptic
2023-02-24
BiOptic has received ISO13485 certification from TÜV Rheinland, which will be a strong asset for us to explore the international market. Relevant primary quality certification includes ISO 9001, ISO 13485, and EU CE.
Congratulations! BiOptic’s core products have successfully registered and listed in FDA!
2023-02-22
BiOptic has recently registered and listed the core products and related consumables in the USA FDA Class I category. Items including Qsep Series Bio-Fragment Analyzers, Qampmini Thermal Cycler and multiple cartridges ,etc. In the future, the above mentioned core products can be sold as medical equipment in the United States, which will expand our business scope in the US market.
